找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: HIV Vaccines and Cure; The Path Towards Fin Linqi Zhang,Sharon R. Lewin Book 2018 Springer Nature Singapore Pte Ltd. 2018 HIV.Cure.Latency.

[復(fù)制鏈接]
查看: 43418|回復(fù): 49
樓主
發(fā)表于 2025-3-21 17:28:06 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱HIV Vaccines and Cure
副標(biāo)題The Path Towards Fin
編輯Linqi Zhang,Sharon R. Lewin
視頻videohttp://file.papertrans.cn/421/420205/420205.mp4
概述Providing a comprehensive review of the major barriers to HIV cure and vaccine.Covering the fundamental virology and immunology of HIV.Discussing the challenges related to development of HIV vaccine a
叢書名稱Advances in Experimental Medicine and Biology
圖書封面Titlebook: HIV Vaccines and Cure; The Path Towards Fin Linqi Zhang,Sharon R. Lewin Book 2018 Springer Nature Singapore Pte Ltd. 2018 HIV.Cure.Latency.
描述.This book provides a comprehensive review of the major barriers to HIV cure and vaccine. It covers the fundamental virology and immunology leading to HIV transmission, protection from infection and long term HIV persistence on antiretroviral therapy. In addition, strategies being tested to eliminate persistent HIV and the rational design of vaccines to induce protective immunity are covered. This book also discusses the challenges related to the design of clinical trials for testing the safety and efficacy of these innovative approaches. This book will provide a systematic overview and also discuss controversial issues for researchers in virology and immunology, as well as practicing physicians, and scientists in the pharmaceutical industry..
出版日期Book 2018
關(guān)鍵詞HIV; Cure; Latency; Vaccine; Antibody; vaccines
版次1
doihttps://doi.org/10.1007/978-981-13-0484-2
isbn_softcover978-981-13-4428-2
isbn_ebook978-981-13-0484-2Series ISSN 0065-2598 Series E-ISSN 2214-8019
issn_series 0065-2598
copyrightSpringer Nature Singapore Pte Ltd. 2018
The information of publication is updating

書目名稱HIV Vaccines and Cure影響因子(影響力)




書目名稱HIV Vaccines and Cure影響因子(影響力)學(xué)科排名




書目名稱HIV Vaccines and Cure網(wǎng)絡(luò)公開度




書目名稱HIV Vaccines and Cure網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱HIV Vaccines and Cure被引頻次




書目名稱HIV Vaccines and Cure被引頻次學(xué)科排名




書目名稱HIV Vaccines and Cure年度引用




書目名稱HIV Vaccines and Cure年度引用學(xué)科排名




書目名稱HIV Vaccines and Cure讀者反饋




書目名稱HIV Vaccines and Cure讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:17:55 | 只看該作者
Book 2018 design of clinical trials for testing the safety and efficacy of these innovative approaches. This book will provide a systematic overview and also discuss controversial issues for researchers in virology and immunology, as well as practicing physicians, and scientists in the pharmaceutical industry..
板凳
發(fā)表于 2025-3-22 03:06:33 | 只看該作者
her vaccine strategies. Trials in Thailand and South Africa have built upon the RV144 framework to provide additional immunologic insights which enable current and future efficacy testing of related vaccine candidates.
地板
發(fā)表于 2025-3-22 04:57:14 | 只看該作者
5#
發(fā)表于 2025-3-22 10:58:41 | 只看該作者
https://doi.org/10.1007/978-1-349-20768-8ter, therefore, we summarize major scientific evidence generated in these models since the beginning of the AIDS pandemic. Hopefully, the accumulated knowledge and lessons contributed by thousands of scientists will be useful in promoting the search of an ultimate solution to end HIV/AIDS.
6#
發(fā)表于 2025-3-22 16:12:52 | 只看該作者
HIV Vaccine Efficacy Trials: RV144 and Beyondher vaccine strategies. Trials in Thailand and South Africa have built upon the RV144 framework to provide additional immunologic insights which enable current and future efficacy testing of related vaccine candidates.
7#
發(fā)表于 2025-3-22 20:13:20 | 只看該作者
HIV Broadly Neutralizing Antibodies: VRC01 and Beyond-depth understanding of the sites of vulnerability on the HIV-1 Env and the complexity of human B cell immunology to generate such responses, thus presenting both guidance and challenges to move the Env immunogen design effort forward.
8#
發(fā)表于 2025-3-22 22:04:05 | 只看該作者
9#
發(fā)表于 2025-3-23 05:06:24 | 只看該作者
0065-2598 ssing the challenges related to development of HIV vaccine a.This book provides a comprehensive review of the major barriers to HIV cure and vaccine. It covers the fundamental virology and immunology leading to HIV transmission, protection from infection and long term HIV persistence on antiretrovir
10#
發(fā)表于 2025-3-23 06:11:59 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 14:36
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
揭西县| 察隅县| 台江县| 鸡泽县| 林口县| 阿拉善盟| 锡林郭勒盟| 册亨县| 洛宁县| 安吉县| 长兴县| 灌阳县| 顺昌县| 陕西省| 汪清县| 资中县| 任丘市| 东明县| 夏河县| 越西县| 达拉特旗| 儋州市| 景谷| 石台县| 西林县| 邢台市| 甘德县| 富锦市| 岳西县| 山东省| 枣阳市| 庆云县| 昆明市| 弥勒县| 连南| 曲阳县| 岳阳市| 宜春市| 内黄县| 鹿邑县| 微山县|